Basit öğe kaydını göster

dc.contributor.authorErgözen, Serkan
dc.contributor.authorGümüş, Tuna
dc.date.accessioned2021-02-23T07:51:16Z
dc.date.available2021-02-23T07:51:16Z
dc.date.issued2021en_US
dc.identifier.citationErgözen S, Gümüş T. Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer: A Letter to the Editor. Complement Med Res. 2021 Feb 18:1-2. doi: 10.1159/000514475. Epub ahead of print. PMID: 33601369.en_US
dc.identifier.issn2504-2106
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/33601369/
dc.identifier.urihttps://hdl.handle.net/20.500.12809/8965
dc.description.abstractLetter to the Editoren_US
dc.description.urihttps://doi.org/10.1159/000514475
dc.item-language.isoengen_US
dc.publisherKargeren_US
dc.relation.isversionof10.1159/000514475en_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChemotherapyen_US
dc.subjectKetogenic dieten_US
dc.subjectHyperthermiaen_US
dc.subjectMetastatic pancreatic canceren_US
dc.titleLong-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer: A Letter to the Editoren_US
dc.item-typeletteren_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0003-1171-3703en_US
dc.contributor.institutionauthorErgözen, Serkan
dc.identifier.doi10.1159/000514475
dc.relation.journalComplementary Medicine Researchen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster